MedPath

Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications

Not Applicable
Not yet recruiting
Conditions
Mental and Behavioural Disorders
Nervous System Diseases
Registration Number
PACTR202204553167288
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
1200
Inclusion Criteria

Children or adults with a diagnosis of epilepsy ascertained by a clinician at the epilepsy clinic
Taking anti-seizure medications at the time of the study
Living within an area defined as the Kilifi Health Demographic Surveillance System, or the Nairobi Urban Health and Demographic Surveillance System at the time of the study or attending the epilepsy clinic in Kilifi or a KAWE-led clinic in Nairobi
Able to give written informed consent or assent in addition to parental consent (if aged between 13 and 17 years old) to participate in the study either by themselves or in the presence of an independent witness

Exclusion Criteria

Have intellectual disability
Do not have access to basic mobile phones
Are currently enrolled in ongoing interventions aimed at improving their health care

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.